Trial
NCT03091439
Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With Osteomyelitis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Allergan
Collaborators
—
Condition
Osteomyelitis
Intervention
Dalbavancin
Why stopped
Business decision outlined by the corporation.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-09-26